CABR Stock Analysis: Buy, Sell, or Hold?
$1.24
0.00 (0.25%)
▲
5d:
-4.62%
30d:
-10.14%
90d:
+0.0%
HOLD
MODERATE Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When CABR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CABR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CABR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CABR is currently trading at $1.24, which is considered fair relative to its 30-day fair value range of $1.18 to $1.36.
Technical Outlook: Technically, CABR is in a uptrend. Immediate support is located at $1.11, while resistance sits at $1.43.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CABR is in a uptrend. Immediate support is located at $1.11, while resistance sits at $1.43.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.18 -
$1.36
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- NEUTRAL: Bottoming setup forming (53/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$1.18 -
$1.36
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.11
Resistance Level
$1.43
Current Trend
Uptrend
Technical data as of
Sep 28, 2026
Fundamental Context
Revenue Growth (YoY)
-9.7%
Share & Embed Analysis
Last updated: September 29, 2026 7:43 AM ET
Data refreshes hourly during market hours. Next update: 8:43 AM
Data refreshes hourly during market hours. Next update: 8:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$208 | 45 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$96 | 51 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 61 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$638 | 49 HOLD |